Back to
CITADEL ADVISORS LLC
IDXG2 quarters
Position history for
CITADEL ADVISORS LLC's holdings in Interpace Biosciences, Inc.
CITADEL ADVISORS LLC previously held 0 shares of IDXG (Interpace Biosciences, Inc.), worth $0 as of 2020-Q4.
Final Value
$0
Final Shares
0
Total Value Change
-$37,000
Total Shares Change
-11,858
Quarter-by-Quarter History
Other major holders of IDXG: GEODE CAPITAL MANAGEMENT, LLC, Squarepoint Ops LLC